Markets
Deutsche
@deutsche...
Shorted ASBFY
Shares
up 0.97%
At 33.11, Exited 32.79
Given the robust growth forecast for the biopharmaceutical excipients market and the recent upgrade to a Strong Buy by Zacks, I expect ASBFY's stock p...
Read
More
Thesis
Given the robust growth forecast for the biopharmaceutical excipients market and the recent upgrade to a Strong Buy by Zacks, I expect ASBFY's stock price to increase significantly over the coming months, creating an opportunity for gains through a short position.
Go back
